BK polyomavirus in solid organ transplantation

American Journal of Transplantation

Volumn 13, Issue SUPPL.4, 2013, Pages 179-188

  Hirsch, H H ^a,b   Randhawa, P ^c  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

BK virus; kidney; nephropathy; polyoma; transplantation

Indexed keywords

CIDOFOVIR; CORTICOSTEROID; IMMUNOGLOBULIN; LEFLUNOMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ARTICLE; BK VIRUS; BK VIRUS INFECTION; BONE MARROW SUPPRESSION; CELLULAR IMMUNITY; GRAFT RECIPIENT; HEMOLYSIS; HEPATITIS; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; LUNG MYCOSIS; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RISK FACTOR; SOLID ORGAN TRANSPLANTATION; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT RESPONSE; VIREMIA; VIRUS LOAD; VIRUS REPLICATION;

ANTIVIRAL AGENTS; BK VIRUS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ORGAN TRANSPLANTATION; POLYOMAVIRUS INFECTIONS; RISK FACTORS; VIRAL LOAD; VIRUS REPLICATION;

EID: 84874917783     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.12110     Document Type: Article

References (114)

1. Randhawa PS, Finkelstein S, Scantlebury V, et al. Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation 1999; 67: 103-109.
2. Binet I, Nickeleit V, Hirsch HH, et al. Polyomavirus disease under new immunosuppressive drugs: A cause of renal graft dysfunction and graft loss. Transplantation 1999; 67: 918-922.
3. Hirsch HH, Knowles W, Dickenmann M, et al. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N Engl J Med 2002; 347: 488-496.
4. Ramos E, Drachenberg CB, Portocarrero M, et al. BK virus nephropathy diagnosis and treatment: Experience at the University of Maryland Renal Transplant Program. Clin Transpl 2002; 143-153.
5. Arthur RR, Shah KV, Baust SJ, Santos GW, Saral R,. Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. N Engl J Med 1986; 315: 230-234.
6. Bedi A, Miller CB, Hanson JL, et al. Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. J Clin Oncol 1995; 13: 1103-1109.
7. Hirsch HH,. Polyoma and Papilloma Virus Infections After Hematopoietic Stem Cell or Solid Organ Transplantation. In:, Bowden P, Ljungman P, Snydman DR, eds. Transplant infections. 3rd Ed. Philadelphia: Lippincott Williams & Wilkins; 2010, pp. 465-482.
8. Dropulic LK, Jones RJ,. Polyomavirus BK infection in blood and marrow transplant recipients. Bone Marrow Transplant 2008; 41: 11-18.
9. Hirsch HH, Steiger J,. Polyomavirus BK. Lancet Infect Dis 2003; 3: 611-623.
10. Elidemir O, Chang IF, Schecter MG, Mallory GB,. BK virus-associated hemorrhagic cystitis in a pediatric lung transplant recipient. Pediatr Transplant 2007; 11: 807-810.
11. Friedman DP, Flanders AE,. MR Imaging of BK virus encephalitis. Am J Neuroradiol 2006; 27: 1016-1018.
12. Hix JK, Braun WE, Isada CM,. Delirium in a renal transplant recipient associated with BK virus in the cerebrospinal fluid. Transplantation 2004; 78: 1407-1408.
13. Hirsch HH,. BK virus: Opportunity makes a pathogen. Clin Infect Dis 2005; 41: 354-360.
14. Masutani K, Shapiro R, Basu A, Tan H, Ninomiya T, Randhawa P,. Putative episodes of T-cell-mediated rejection in patients with sustained BK viruria but no viremia. Transplantation 2012; 94: 43-49.
15. Knowles WA, Pipkin P, Andrews N, et al. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40. J Med Virol 2003; 71: 115-123.
16. Egli A, Infanti L, Dumoulin A, et al. Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J Infect Dis 2009; 199: 837-846.
17. Antonsson A, Green AC, Mallitt KA, et al. Prevalence and stability of antibodies to the BK and JC polyomaviruses: A long-term longitudinal study of Australians. J Gen Virol 2010; 91 (Pt 7): 1849-1853.
18. Chesters PM, Heritage J, McCance DJ,. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J Infect Dis 1983; 147: 676-684.
19. Nickeleit V, Hirsch HH, Binet IF, et al. Polyomavirus infection of renal allograft recipients: From latent infection to manifest disease. J Am Soc Nephrol 1999; 10: 1080-1089.
20. Drachenberg CB, Beskow CO, Cangro CB, et al. Human polyoma virus in renal allograft biopsies: Morphological findings and correlation with urine cytology. Hum Pathol 1999; 30: 970-977.
21. Drachenberg RC, Drachenberg CB, Papadimitriou JC, et al. Morphological spectrum of polyoma virus disease in renal allografts: Diagnostic accuracy of urine cytology. Am J Transplant 2001; 1: 373-381.
22. Randhawa P, Uhrmacher J, Pasculle W, et al. A comparative study of BK and JC virus infections in organ transplant recipients. J Med Virol 2005; 77: 238-243.
23. Thomas LD, Vilchez RA, White ZS, et al. A prospective longitudinal study of polyomavirus shedding in lung-transplant recipients. J Infect Dis 2007; 195: 442-449.
24. Doucette KE, Pang XL, Jackson K, et al. Prospective monitoring of BK polyomavirus infection early posttransplantation in nonrenal solid organ transplant recipients. Transplantation 2008; 85: 1733-1736.
25. Haririan A, Ramos ER, Drachenberg CB, Weir MR, Klassen DK,. Polyomavirus nephropathy in native kidneys of a solitary pancreas transplant recipient. Transplantation 2002; 73: 1350-1353.
26. Barber CE, Hewlett TJ, Geldenhuys L, Kiberd BA, Acott PD, Hatchette TF,. BK virus nephropathy in a heart transplant recipient: Case report and review of the literature. Transpl Infect Dis 2006; 8: 113-121.
27. Nickeleit V, Klimkait T, Binet IF, et al. Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy. N Engl J Med 2000; 342: 1309-1315.
28. Drachenberg CB, Hirsch HH, Papadimitriou JC, et al. Polyomavirus BK versus JC replication and nephropathy in renal transplant recipients: A prospective evaluation. Transplantation 2007; 84: 323-330.
29. Viscount HB, Eid AJ, Espy MJ, et al. Polyomavirus polymerase chain reaction as a surrogate marker of polyomavirus-associated nephropathy. Transplantation 2007; 84: 340-345.
30. Ramos E, Drachenberg CB, Papadimitriou JC, et al. Clinical course of polyoma virus nephropathy in 67 renal transplant patients. J Am Soc Nephrol 2002; 13: 2145-2151.
31. Wadei HM, Rule AD, Lewin M, et al. Kidney transplant function and histological clearance of virus following diagnosis of polyomavirus-associated nephropathy (PVAN). Am J Transplant 2006; 6 (Pt 1): 1025-1032.
32. Ginevri F, Azzi A, Hirsch HH, et al. Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am J Transplant 2007; 7: 2727-2735.
33. Binggeli S, Egli A, Schaub S, et al. Polyomavirus BK-specific cellular immune response to VP1 and large T-antigen in kidney transplant recipients. Am J Transplant 2007; 7: 1131-1139.
34. Schachtner T, Muller K, Stein M, et al. BK virus-specific immunity kinetics: A predictor of recovery from polyomavirus BK-associated nephropathy. Am J Transplant 2011; 11: 2443-2452.
35. Krymskaya L, Sharma MC, Martinez J, et al. Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides. J Virol 2005; 79: 11170-11178.
36. Hirsch HH, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: Interdisciplinary analyses and recommendations. Transplantation 2005; 79: 1277-1286.
37. Dharnidharka VR, Cherikh WS, Abbott KC,. An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States. Transplantation 2009; 87: 1019-1026.
38. Schold JD, Rehman S, Kayler LK, Magliocca J, Srinivas TR, Meier-Kriesche HU,. Treatment for BK virus: Incidence, risk factors and outcomes for kidney transplant recipients in the United States. Transpl Int 2009; 22: 626-634.
39. Hirsch HH, Vincenti F, Friman S, et al., Polyomavirus BK, replication in de novo kidney transplant patients receiving tacrolimus or cyclosporine: A prospective, randomized, multicenter study. Am J Transplant 2013; 13: 136-145.
40. Manitpisitkul W, Drachenberg C, Ramos E, et al. Maintenance immunosuppressive agents as risk factors for BK virus nephropathy: A case-control study. Transplantation 2009; 88: 83-88.
41. Prince O, Savic S, Dickenmann M, Steiger J, Bubendorf L, Mihatsch MJ,. Risk factors for polyoma virus nephropathy. Nephrol Dial Transplant 2009; 24: 1024-1033.
42. Hirsch HH, Vincenti V, Friman S, et al. Risk factors of polyomavirus BKV high-level viruria and viremia in de novo renal transplantation: A multivariate analysis from the DIRECT Study comparing cyclosporine and tacrolimus (Abstract #1664). Transplantation 2010.
43. Almeras C, Vetromile F, Garrigue V, Szwarc I, Foulongne V, Mourad G,. Monthly screening for BK viremia is an effective strategy to prevent BK virus nephropathy in renal transplant recipients. Transpl Infect Dis 2011; 13: 101-108.
44. Schaub S, Hirsch HH, Dickenmann M, Steiger J, Mihatsch MJ, Hopfer H, Mayr M,. Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy. Am J Transplant 2010; 10: 2615-2623.
45. Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Am J Transplant 2005; 5: 582-594.
46. Ginevri F, Azzi A, Hirsch HH, et al. Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am J Transplant 2007; 7: 2727-2735.
47. Kasiske BL, Zeier MG, Chapman JR, et al. KDIGO clinical practice guideline for the care of kidney transplant recipients: A summary. Kidney Int 2009; 9 (Suppl 3): S1-S155.
48. Kiberd BA,. Screening to prevent polyoma virus nephropathy: A medical decision analysis. Am J Transplant 2005; 5: 2410-2416.
49. Smith F, Panek R, Kiberd BA,. Screening to prevent polyoma virus nephropathy in kidney transplantation: A cost analysis. Am J Transplant 2009; 9: 2177-2179.
50. Drachenberg CB, Papadimitriou JC, Hirsch HH, et al. Histological patterns of polyomavirus nephropathy: Correlation with graft outcome and viral load. Am J Transplant 2004; 4: 2082-2092.
51. Funk GA, Gosert R, Comoli P, Ginevri F, Hirsch HH,. Polyomavirus BK replication dynamics in vivo and in silico to predict cytopathology and viral clearance in kidney transplants. Am J Transplant 2008; 8: 2368-2377.
52. Hymes LC, Warshaw BL,. Polyomavirus (BK) in pediatric renal transplants: Evaluation of viremic patients with and without BK associated nephritis. Pediatr Transplant 2006; 10: 920-922.
53. Gosert R, Rinaldo CH, Funk GA, et al. Polyomavirus BK with rearranged noncoding control region emerge in vivo in renal transplant patients and increase viral replication and cytopathology. J Exp Med 2008; 205: 841-852.
54. Pollara CP, Corbellini S, Chiappini S, et al. Quantitative viral load measurement for BKV infection in renal transplant recipients as a predictive tool for BKVAN. New Microbiol 2011; 34: 165-171.
55. Anzivino E, Bellizzi A, Mitterhofer AP, et al. Early monitoring of the human polyomavirus BK replication and sequencing analysis in a cohort of adult kidney transplant patients treated with basiliximab. Virol J 2011; 8: 407.
56. Singh HK, Andreoni KA, Madden V, et al. Presence of urinary haufen accurately predicts polyomavirus nephropathy. J Am Soc Nephrol 2009; 20: 416-427.
57. Randhawa P, Vats A, Shapiro R,. Monitoring for polyomavirus BK and JC in urine: Comparison of quantitative polymerase chain reaction with urine cytology. Transplantation 2005; 79: 984-986.
58. Koukoulaki M, O'Donovan M, Pursglove S, Alexopoulou D, Hadjiconstantinou V, Drakopoulos S,. Prospective study of urine cytology screening for BK polyoma virus replication in renal transplant recipients. Cytopathology 2008; 19: 385-388.
59. Luo C, Bueno M, Kant J, Randhawa P,. Biologic diversity of polyomavirus BK genomic sequences: Implications for molecular diagnostic laboratories. J Med Virol 2008; 80: 1850-1857.
60. Hoffman NG, Cook L, Atienza EE, Limaye AP, Jerome KR,. Marked variability of BK virus load measurement using quantitative real-time PCR among commonly used assays. Journal Clin Microbiol 2008; 46: 2671-2680.
61. Dumoulin A, Hirsch HH,. Reevaluating and optimizing polyomavirus BK and JC real-time PCR assays to detect rare sequence polymorphisms. J Clin Microbiol 2011; 49: 1382-1388.
62. Randhawa PS, Chan S, Climenhaga J, et al. The Banff Initiative for Quality Assurance in Transplantation (BIFQUIT): Immunohistochemistry for BK virus in the kidney. In: Proceedings of the US and Canadian Academy of Pathology Meeting; March 20, 2012; Canada: Vancouver; 2012.
63. Funk GA, Steiger J, Hirsch HH,. Rapid dynamics of polyomavirus type BK in renal transplant recipients. J Infect Dis 2006; 193: 80-87.
64. Kemeny E, Hirsch HH, Eller J, Dürmüller U, Mihatsch MJ,. Plasma cell infiltrates in polyomavirus-associated nephropathy Transpl Int 2010; 23: 397-406.
65. Sar A, Worawichawong S, Benediktsson H, Zhang J, Yilmaz S, Trpkov K,. Interobserver agreement for Polyomavirus nephropathy grading in renal allografts using the working proposal from the 10th Banff Conference on Allograft Pathology. Hum Pathol 2011; 42: 2018-2014.
66. Masutani K, Shapiro R, Basu A, Tan H, Wijkstrom M, Randhawa P,. The Banff 2009 Working Proposal for polyomavirus nephropathy: A critical evaluation of its utility as a determinant of clinical outcome. Am J Transplant 2012; 12: 907-918.
67. Dadhania D, Snopkowski C, Ding R, et al. Validation of noninvasive diagnosis of BK virus nephropathy and identification of prognostic biomarkers. Transplantation 2010; 90: 189-197.
68. Batal I, Franco ZM, Shapiro R, et al. Clinicopathologic analysis of patients with BK viruria and rejection-like graft dysfunction. Hum Pathol. 2009; 40: 1312-1319.
69. McGilvray ID, Lajoie G, Humar A, Cattral MS,. Polyomavirus infection and acute vascular rejection in a kidney allograft: Coincidence or mimicry ? Am J Transplant. 2003; 3: 501-504.
70. Petrogiannis-Haliotis T, Sakoulas G, Kirby J, et al. BK-related polyomavirus vasculopathy in a renal-transplant recipient. N Engl J Med 2001; 345: 1250-1255.
71. Nickeleit V, Hirsch HH, Zeiler M, et al. BK-virus nephropathy in renal transplants-tubular necrosis, MHC-class II expression and rejection in a puzzling game. Nephrol Dial Transplant 2000; 15: 324-332.
72. Mannon RB, Hoffmann SC, Kampen RL, et al. Molecular evaluation of BK polyomavirus nephropathy. Am J Transplant 2005; 5: 2883-2893.
73. Jahnukainen T, Malehorn D, Sun M, et al. Proteomic analysis of urine in kidney transplant patients with BK virus nephropathy. J Am Soc Nephrol 2006; 17: 3248-3256.
74. Kazory A, Ducloux D, Chalopin JM, Angonin R, Fontaniere B, Moret H,. The first case of JC virus allograft nephropathy. Transplantation 2003; 76: 1653-1655.
75. Mengelle C, Kamar N, Mansuy JM, et al. JC virus DNA in the peripheral blood of renal transplant patients: A 1-year prospective follow-up in France. J Med Virol 2011; 83: 132-136.
76. Wen MC, Wang CL, Wang M, et al. Association of JC virus with tubulointerstitial nephritis in a renal allograft recipient. J Med Virol 2004; 72: 675-678.
77. Comoli P, Binggeli S, Ginevri F, Hirsch HH,. Polyomavirus-associated nephropathy: Update on BK virus-specific immunity. Transpl Infect Dis 2006; 8: 86-94.
78. Comoli P, Hirsch HH, Ginevri F,. Cellular immune responses to BK virus. Curr Opin Organ Transplant 2008; 13: 569-574.
79. Wu SW, Chang HR, Hsieh MC, Chiou HL, Lin CC, Lian JD,. Early diagnosis of polyomavirus type BK infection in tailoring immunosuppression for kidney transplant patients: Screening with urine qualitative polymerase chain reaction assay. Transplant Proc 2008; 40: 2389-2391.
80. Almeras C, Foulongne V, Garrigue V, et al. Does reduction in immunosuppression in viremic patients prevent BK virus nephropathy in de novo renal transplant recipients? A prospective study. Transplantation 2008; 85: 1099-1104.
81. Ahn HJ, Ju MK, Jeong HJ, et al. Immunologic control for polyomavirus infection after kidney transplantation. Nephron Clin Pract 2008; 108: c148-c154.
82. Hymes LC, Greenbaum L, Amaral SG, Warshaw BL,. Surveillance renal transplant biopsies and subclinical rejection at three months post-transplant in pediatric recipients. Pediatr Transplant 2007; 11: 536-539.
83. Giraldi C, Noto A, Tenuta R, et al. Prospective study of BKV nephropathy in 117 renal transplant recipients. New Microbiol 2007; 30: 127-1230.
84. Egli A, Kohli S, Dickenmann M, Hirsch HH,. Inhibition of polyomavirus BK-specific T-Cell responses by immunosuppressive drugs. Transplantation 2009; 88: 1161-1168.
85. Kuypers DR, Bammens B, Claes K, Evenepoel P, Lerut E, Vanrenterghem Y,. A single-centre study of adjuvant cidofovir therapy for BK virus interstitial nephritis (BKVIN) in renal allograft recipients. J Antimicrob Chemother 2009; 63: 417-419.
86. Lopez V, Sola E, Gutierrez C, et al. Anterior uveitis associated with treatment with intravenous cidofovir in kidney transplant patients with BK virus nephropathy. Transplant Proc 2006; 38: 2412-2413.
87. Vats A, Shapiro R, Singh Randhawa P, et al. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults. Transplantation 2003; 75: 105-112.
88. Araya CE, Lew JF, Fennell RS, Neiberger RE, Dharnidharka VR,. Intermediate dose cidofovir does not cause additive nephrotoxicity in BK virus allograft nephropathy. Pediatr Transplant 2008; 12: 790-795.
89. Josephson MA, Gillen D, Javaid B, et al. Treatment of renal allograft polyoma BK virus infection with leflunomide. Transplantation 2006; 81: 704-710.
90. Wu SW, Chang HR, Lian JD,. The effect of low-dose cidofovir on the long-term outcome of polyomavirus-associated nephropathy in renal transplant recipients. Nephrol Dial Transplant 2009; 24: 1034-1038.
91. Rinaldo CH, Hirsch HH,. Antivirals for the treatment of polyomavirus BK replication. Expert Rev Anti Infect Ther 2007; 5: 105-115.
92. Kuypers DR, Vandooren AK, Lerut E, et al. Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients. Am J Transplant 2005; 5: 1997-2004.
93. Farasati NA, Shapiro R, Vats A, Randhawa P,. Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system. Transplantation 2005; 79: 116-118.
94. Bernhoff E, Gutteberg TJ, Sandvik K, Hirsch HH, Rinaldo CH,. Cidofovir inhibits polyomavirus BK replication in human renal tubular cells downstream of viral early gene expression. Am J Transplant 2008; 8: 1413-1422.
95. Randhawa P, Farasati NA, Shapiro R, Hostetler KY,. Ether lipid ester derivatives of cidofovir inhibit polyomavirus BK replication in vitro. Antimicrob Agents Chemother 2006; 50: 1564-1566.
96. Rinaldo CH, Gosert R, Bernhoff E, Finstad S, Hirsch HH,. 1-O-hexadecyloxypropyl cidofovir (CMX001) effectively inhibits polyomavirus BK replication in primary human renal tubular epithelial cells. Antimicrob Agents Chemother 2010; 54: 4714-4722.
97. Josephson MA, Williams JW, Chandraker A, Randhawa PS,. Polyomavirus-associated nephropathy: Update on antiviral strategies. Transpl Infect Dis 2006; 8: 95-101.
98. Williams JW, Javaid B, Kadambi PV, et al. Leflunomide for polyomavirus type BK nephropathy. N Engl J Med 2005; 352: 1157-1158.
99. Faguer S, Hirsch HH, Kamar N, et al. Leflunomide treatment for polyomavirus BK-associated nephropathy after kidney transplantation. Transpl Int 2007; 20: 962-969.
100. Sener A, House AA, Jevnikar AM, et al. Intravenous immunoglobulin as a treatment for BK virus associated nephropathy: One-year follow-up of renal allograft recipients. Transplantation 2006; 81: 117-120.
101. Randhawa P, Viscidi R, Carter JJ, et al. Identification of species-specific and cross-reactive epitopes in human polyomavirus capsids using monoclonal antibodies. J Gen Virol 2009; 90 (Pt 3): 634-639.
102. Sharma BN, Li R, Bernhoff E, Gutteberg TJ, Rinaldo CH,. Fluoroquinolones inhibit human polyomavirus BK (BKV) replication in primary human kidney cells. Antiviral Res 2011; 92: 115-123.
103. Leung AY, Chan MT, Yuen KY, et al. Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation. Clin Infect Dis 2005; 40: 528-537.
104. Gabardi S, Waikar SS, Martin S, et al. Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation. Clin J Am Soc Nephrol 2010; 5: 1298-304.
105. Randhawa PS, Gupta G, Vats A, Shapiro R, Viscidi RP,. Immunoglobulin G, A, and M responses to BK virus in renal transplantation. Clin Vaccine Immunol 2006; 13: 1057-1063.
106. Thamboo TP, Jeffery KJ, Friend PJ, Turner GD, Roberts IS,. Urine cytology screening for polyoma virus infection following renal transplantation: The Oxford experience. J Clin Pathol 2007; 60: 927-930.
107. Schaub S, Mayr M, Egli A, et al. Transient allograft dysfunction from immune reconstitution in a patient with polyoma BK-virus-associated nephropathy. Nephrol Dial Transplant 2007; 22: 2386-2390.
108. Dharnidharka VR, Cherikh WS, Neff R, Cheng Y, Abbott KC,. Retransplantation after BK virus nephropathy in prior kidney transplant: An OPTN database analysis. Am J Transplant 2010; 10: 1312-1315.
109. Hirsch HH, Ramos E,. Retransplantation after polyomavirus-associated nephropathy: Just do it? Am J Transplant 2006; 6: 7-9.
110. Ginevri F, Pastorino N, de Santis R, et al. Retransplantation after kidney graft loss due to polyoma BK virus nephropathy: Successful outcome without original allograft nephrectomy. Am J Kidney Dis 2003; 42: 821-825.
111. Womer KL, Meier-Kriesche HU, Patton PR, et al. Preemptive retransplantation for BK virus nephropathy: Successful outcome despite active viremia. Am J Transplant 2006; 6: 209-213.
112. Mindlova M, Boucek P, Saudek F, et al. Kidney retransplantation following graft loss to polyoma virus-associated nephropathy: An effective treatment option in simultaneous pancreas and kidney transplant recipients. Transpl Int 2007; 21: 353-356.
113. Ramos E, Drachenberg CB, Wali R, Hirsch HH,. The decade of polyomavirus BK-associated nephropathy: State of affairs. Transplantation 2009; 87: 621-630.
114. Hirsch HH, Randhawa P,. BK virus in solid organ transplant recipients. Am J Transplant 2009; 9 (Suppl 4): S136-S146.